(OVERVIEW) The NIDDK P30 Digestive Diseases Research Core Center at the University of Pennsylvania is called the Center for Molecular Studies in Digestive and Liver Diseases (CMSDLD). Constituted in 1997 and funded continuously since then (with highly successful competitive renewals in 2002, 2007 and 2012), the CMSDLD provides an exceptional platform for basic and translational research in digestive, liver and pancreatic diseases with a vision of understanding human health and ameliorating the public health burden associated with these diseases. This overarching vision is executed through the interrelated missions or Specific Aims of the CMSDLD: (1) to support impactful interdisciplinary and collaborative digestive, liver and pancreatic research through its Members/Associate Members, who span 4 Schools at the University of Pennsylvania, multiple Departments/Centers/Institutes, importantly, Children's Hospital of Philadelphia, as well as institutions within and surrounding Philadelphia; (2) to foster the academic and professional development of its Associate Members; (3) to provide state-of-the art services and technologies through its scientific core facilities (with quality and cost-effectiveness), which in turn support the Members and Associate Members; (4) to oversee innovative enrichment (inclusive of education and mentorship) programs and a highly successful pilot and feasibility grant program; (5) to promote gender, diversity and inclusion as part of our CREED (Clinical care, Research, Education, Encouragement and Diversity) and (6) to collaborate with other Penn Centers/Institutes as well as national universities, academic medical centers, other DDRCCs and the NIH/NIDDK, and conduct outreach with the lay public. Rigor, reproducibility and transparency are also critical aspects of the CMSDLD. The CMSDLD has an administrative structure, or Core, which is overseen by the Dean, and guidance from highly interactive Penn/CHOP leaders, and internal and external advisory boards. The CMSDLD may be viewed as a stem cell, which self-renews and concurrently gives rise to differentiated entities on campus that in turn continue to interact with the CMSDLD: (A) Members who apply for and receive new interdisciplinary grants spawned by the CMSDLD; (B) Penn-CHOP Joint Center in Transitional Medicine (adolescence to adulthood) in digestive, liver and pancreatic medicine; (C) Penn-CHOP Microbiome Program. The Perelman School of Medicine and Children's Hospital of Philadelphia have invested heavily in the CMSDLD and are committed to continue to do so in the next funding cycle. The CMSDLD is positioned to build upon its successes and be a vanguard of research, education and translational clinical care in the future.

Public Health Relevance

(OVERVIEW) The Center for Molecular Studies in Digestive and Liver Diseases (CMSLD) is a DDRCC that seeks to catalyze advances in impactful digestive, liver and pancreatic research. These discoveries are translated to improving patients with digestive, liver and pancreatic diseases through innovations in diagnosis, prognosis and therapy.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Perrin, Peter J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Aiello, Nicole M; Maddipati, Ravikanth; Norgard, Robert J et al. (2018) EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev Cell 45:681-695.e4
Whelan, Kelly A; Muir, Amanda B; Nakagawa, Hiroshi (2018) Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. Cell Mol Gastroenterol Hepatol 5:461-478
Friedman, Elliot S; Bittinger, Kyle; Esipova, Tatiana V et al. (2018) Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A 115:4170-4175
Chatterji, Priya; Rustgi, Anil K (2018) RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer. Trends Mol Med 24:490-506
Wang, Amber W; Wangensteen, Kirk J; Wang, Yue J et al. (2018) TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury. J Clin Invest 128:2297-2309
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253
Giroux, VĂ©ronique; Stephan, Julien; Chatterji, Priya et al. (2018) Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports 10:1947-1958
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705
Wangensteen, Kirk J; Wang, Yue J; Dou, Zhixun et al. (2018) Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology 68:663-676
Andres, Sarah F; Williams, Kathy N; Rustgi, Anil K (2018) The Molecular Basis of Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 14:69-79

Showing the most recent 10 out of 700 publications